Toggle light / dark theme

Prof. Dr. Alan Widgerow — Division Chief, Center for Tissue Engineering, UC Irvine / CSO, Galderma

Innovation At The Frontiers Of Aesthetic And Regenerative Medicine — Prof. Dr. Alan Widgerow — Division Chief, Center for Tissue Engineering, UCIrvine — Chief Scientific Officer, Galderma.


Prof. Dr. Alan Widgerow, MBBCh, FCS, MMed, FACS, is Division Chief, Research, Center for Tissue Engineering (https://sites.uci.edu/ctelab/team/) and Adjunct Professor Plastic Surgery, Dept of Plastic Surgery, University of California, Irvine (https://faculty.uci.edu/profile/?facu…) and Chief Scientific Officer and Head of Skin Science Center of Innovation at Galderma (https://www.galderma.com/).

Prof. Widgerow is a plastic surgeon who ran a solo private practice in South Africa for over 20 years.

Prof. Widgerow completed his undergraduate and post-graduate studies at the University of the Witwatersrand, South Africa. He has held various positions in numerous academic and professional associations including that of President of the Association of Plastic and Reconstructive surgery of Southern Africa (APRSSA). He is author of over 190 plastic surgical related publications and 2 books. He was also the founder and medical director of 13 wound clinics in South Africa.

Prof. Widgerow relocated to Irvine California in Dec 2009 to pursue his interests in medical device innovations, cosmeceuticals and wound care, but he still plays an active role in academic medicine world-wide. In 2012 he was appointed to the Faculty of the University of California Irvine Plastic Surgery Dept as Full Adjunct Professor and Director of the Center for Tissue Engineering and in 2021 was appointed as its Division Chief of Research. He is involved in multiple projects related to adipose derived stem cell and adipose decellularized matrix, wound healing and transplantation. In 2018 he was awarded the Distinguished Faculty Mentor of the year Award by the Institute for Clinical and Translational Science, UCI.

Sheba Study: AI Can Spot Patients At Risk Of Pulmonary Embolism

A newly published study by Sheba Medical Center, Israel’s largest and internationally ranked hospital, shows that AI analysis of medical records as patients are admitted to the ER can accurately identify those at high risk of pulmonary embolism (PE).

A pulmonary embolism is a sudden blockage in an artery in the lung caused by a blood clot, most commonly due to a dislodged clot in the leg. They are normally diagnosed during a CT scan.

Using machine learning, the researchers trained an algorithm to detect a pulmonary embolism before a patient was hospitalized, based on existing medical records.

Custom Implants on Demand? Bandages for the Heart? 3D Printing Method Makes It Possible

University of Colorado at Boulder News

In the quest to develop life-like materials to replace and repair human body parts, scientists face a formidable challenge: Real tissues are often both strong and stretchable and vary in shape and size.

A CU Boulder-led team, in collaboration with researchers at the University of Pennsylvania, has taken a critical step toward cracking that code. They’ve developed a new way to 3D print material that is at once elastic enough to withstand a heart’s persistent beating, tough enough to endure the crushing load placed on joints, and easily shapable to fit a patient’s unique defects.

Metformin and the TAME trial: a conversation with Nir Barzilai and Brad Stanfield

In this interview, hosted by Nicolás Cherñavsky, Nir Barzilai and Brad Stanfield discuss metformin, whether or not to use it in non-diabetic patients to slow aging, and the TAME trial.

Nir Barzilai is president of the Academy of Health and Lifespan Research (https://www.ahlresearch.org/), and Brad Stanfield is a primary care physician in Auckland (New Zealand) and runs a YouTube channel (/ @drbradstanfield) with around 250,000 subscribers to explore the latest research and preventive care guidelines.

Host: Nicolás Cherñavsky.
Production: Nicolás Cherñavsky and Nina Torres Zanvettor.
Editing: Nina Torres Zanvettor.
Revision and subtitling: Nicolás Cherñavsky.

============================================================
Notes:
TAME trial website: https://www.afar.org/tame-trial.
Diabetes Prevention Program Outcomes Study (DPPOS): https://repository.niddk.nih.gov/stud
UK metformin vs sulfonylurea trial on type 2 diabetics: https://www.cmajopen.ca/content/2/3/E162
The New England Journal of Medicine paper on metformin treatment in Covid-19 patients: https://www.nejm.org/doi/full/10.1056
Lancet paper on metformin treatment in Covid-19 patients: https://www.thelancet.com/journals/la
Andre Scott’s paper on the cost-effectiveness of treating aging: https://www.nature.com/articles/s4358
Medical guidelines database mentioned by Brad Stanfield: https://uptodate.com.
============================================================

Heales website (Healthy Life Extension Society): https://heales.org/

Contact e-mail: [email protected].

Breakthrough molecule reverses Alzheimer’s symptoms

In a new study, a molecule identified and synthesized by UCLA Health researchers was shown to restore cognitive functions in mice with symptoms of Alzheimer’s disease by effectively jumpstarting the brain’s memory circuitry.

If proven to have similar effects in humans, the candidate compound would be novel among Alzheimer’s disease treatments in its ability to revitalize memory and cognition, study authors said.

There is really nothing like this on the market or experimentally that has been shown to do this.

Researchers identify body’s ‘quality control’ regulator for protein folding, could lead to targeted treatments

Anyone who’s tried to neatly gather a fitted sheet can tell you: folding is hard. Get it wrong with your laundry and the result can be a crumpled, wrinkled mess of fabric, but when folding fails among the approximately 7,000 proteins with an origami-like complexity that regulate essential cellular functions, the result can lead to one of a multitude of serious diseases ranging from emphysema and cystic fibrosis to Alzheimer’s disease.

State-of-the-art brain recordings reveal how neurons resonate

For decades, scientists have focused on how the brain processes information in a hierarchical manner, with different brain areas specialized for different tasks. However, how these areas communicate and integrate information to form a coherent whole has remained a mystery.

Now, researchers at University of California San Diego School of Medicine have brought us closer to solving it by observing how neurons synchronize across the human brain while reading. The findings are published in Nature Human Behavior and are also the basis of a thesis by UC San Diego School of Medicine doctoral candidate Jacob Garrett.

“How the activity of the brain relates to the subjective experience of consciousness is one of the fundamental unanswered questions in modern neuroscience,” said study senior author Eric Halgren, Ph.D., professor in the Departments of Neurosciences and Radiology at UC San Diego School of Medicine.

3D-Printing Heart Tissue With Human Stem Cells

Year 2023 face_with_colon_three


Scientists at Stanford University have developed a method for 3D-printing human heart tissue that could eventually be implanted into patients.

0:00 Intro.
0:45 How scientists are 3D Printing heart parts.
1:25 Bioprinting process.
2:45 Bio-printed heart valve.
3:44 Outro.

Read the CNET article.
Stanford Scientists Use Stem Cells to 3D-Print Heart Tissue.
https://www.cnet.com/science/stanford

Never miss a deal again! See CNET’s browser extension 👉 https://bit.ly/3lO7sOU

/* */